These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27184069)

  • 21. [Advances in genetyping of Toxoplasma gondii].
    Jia YX; Nie DP; Chen LJ; Li W; Shen LJ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Apr; 25(2):202-4. PubMed ID: 23894847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes.
    Sidik SM; Huet D; Ganesan SM; Huynh MH; Wang T; Nasamu AS; Thiru P; Saeij JPJ; Carruthers VB; Niles JC; Lourido S
    Cell; 2016 Sep; 166(6):1423-1435.e12. PubMed ID: 27594426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9.
    Du H; Zeng X; Zhao M; Cui X; Wang Q; Yang H; Cheng H; Yu D
    J Biotechnol; 2016 Jan; 217():90-7. PubMed ID: 26603121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved techniques for endogenous epitope tagging and gene deletion in Toxoplasma gondii.
    Upadhya R; Kim K; Hogue-Angeletti R; Weiss LM
    J Microbiol Methods; 2011 May; 85(2):103-13. PubMed ID: 21352857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of germ-line-specific CRISPR-Cas9 systems to improve the production of heritable gene modifications in Arabidopsis.
    Mao Y; Zhang Z; Feng Z; Wei P; Zhang H; Botella JR; Zhu JK
    Plant Biotechnol J; 2016 Feb; 14(2):519-32. PubMed ID: 26360626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of genome editing technologies to the study and treatment of hematological disease.
    Pellagatti A; Dolatshad H; Yip BH; Valletta S; Boultwood J
    Adv Biol Regul; 2016 Jan; 60():122-134. PubMed ID: 26433620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
    Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
    Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advantages of using the CRISPR/Cas9 system of genome editing to investigate male reproductive mechanisms using mouse models.
    Young SA; Aitken RJ; Ikawa M
    Asian J Androl; 2015; 17(4):623-7. PubMed ID: 25994645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-Cas9 for medical genetic screens: applications and future perspectives.
    Xue HY; Ji LJ; Gao AM; Liu P; He JD; Lu XJ
    J Med Genet; 2016 Feb; 53(2):91-7. PubMed ID: 26673779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of inherent miRNAs in functional analyses of Toxoplasma gondii genes.
    Crater AK; Manni E; Ananvoranich S
    J Microbiol Methods; 2015 Jan; 108():92-102. PubMed ID: 25479428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput screens in mammalian cells using the CRISPR-Cas9 system.
    Peng J; Zhou Y; Zhu S; Wei W
    FEBS J; 2015 Jun; 282(11):2089-96. PubMed ID: 25731961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of magnetic capture in comparison with conventional DNA isolation in a survey of Toxoplasma gondii in wild house mice.
    Juránková J; Hůrková-Hofmannová L; Volf J; Baláž V; Piálek J
    Eur J Protistol; 2014 Feb; 50(1):11-5. PubMed ID: 24280460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic characterization of Toxoplasma gondii isolates from pigs in China.
    Zhou P; Nie H; Zhang LX; Wang HY; Yin CC; Su C; Zhu XQ; Zhao JL
    J Parasitol; 2010 Oct; 96(5):1027-9. PubMed ID: 20481661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In control of its fate: gene regulation in Toxoplasma gondii.
    Mattsson JG; Erhardt H; Soldati D
    Behring Inst Mitt; 1997 Mar; (99):25-33. PubMed ID: 9303199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Guide to Computational Tools and Design Strategies for Genome Editing Experiments in Zebrafish Using CRISPR/Cas9.
    Prykhozhij SV; Rajan V; Berman JN
    Zebrafish; 2016 Feb; 13(1):70-3. PubMed ID: 26683213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clonal types of Toxoplasma gondii among immune compromised and immune competent individuals in Accra, Ghana.
    Ayi I; Kwofie KD; Blay EA; Osei JH; Frempong KK; Koku R; Ghansah A; Lartey M; Suzuki T; Boakye DA; Koram KA; Ohta N
    Parasitol Int; 2016 Jun; 65(3):238-44. PubMed ID: 26775819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR/Cas9 for genome editing: progress, implications and challenges.
    Zhang F; Wen Y; Guo X
    Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.